Bill Wilson, MD Breaks Down Why Inflammation, Not Fat, Is the Real Enemy—and How GLP-1s Help
Short transcript excerpt of a conversation (April 11, 2025 upload) where Bill Wilson, MD and another speaker argue that excess inflammation—not body fat—is a primary driver of many chronic diseases (diabetes, insulin resistance, brain problems). They recommend simple interventions (diet, exercise) and mention supplements (Apicurb) and GLP-1 medications as potentially beneficial. Wilson notes GLP-1s could help many people but that use depends on availability, cost, and finding a prescriber; he states he is not prescribing advice and frames safety as conditional on access and oversight.
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet